Table 2 Univariate and multivariate analyses of ADRB2 and clinical pathological parameters associated with survival in patients with LUAD.

From: ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinoma

Parameter

Univariate analysis

Multivariate analysis

HR

95% CI

P

HR

95% CI

P

Age

1.223

0.916–1.635

0.172

1.256

0.881–1.792

0.208

Smoker

0.894

0.592–1.348

0.591

0.896

0.536–1.498

0.676

Gender

1.070

0.803–1.426

0.642

0.969

0.681–1.379

0.861

Pathological stage

2.664

1.960–3.621

 < 0.001

1.341

0.805–2.233

0.260

T stage

2.317

1.591–3.375

 < 0.001

1.817

1.119–2.951

0.016

N stage

2.601

1.944–3.480

 < 0.001

2.086

1.387–3.139

 < 0.001

M stage

2.136

1.248–3.653

0.006

1.263

0.654–2.450

0.490

ADRB2

0.612

0.456–0.821

0.001

0.730

0.504–1.056

0.095

Back to article page